The deletion of Slc6a14 protected mice from colon cancer, while it’s silencing or blocking with its specific blocker - α-methyltryptophan (α-MT) (Karunakaran et al., 2008) led to a reduced tumor growth and suppressed proliferation due to autophagy and apoptosis. Here, SLC6A14 is linked to malignant colon neoplasm.